RxDoctor Payments Data

Melissa Franco, DO

Family Medicine · Palmetto Bay, FLNPI 1023266319

Payments from drug & device makers

$1,478in general payments, 2019–2025

Across 71 payments — averaging $20.82 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$254
  • Amgen$196
  • Abbott$127
  • Lilly USA, LLC$114
  • Alnylam Pharmaceuticals Inc.$105
  • Astellas Pharma US Inc$86
  • plus $596 from 12 others

What the payments were for

  • Food & beverage$1,41596%
  • Other$634%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,478 in reported general payments places this provider in the 70th percentile of 7,282 family medicine providers in Florida.

See all family medicine providers in Florida

Medicare billing

Part B allowed, 2024
$96,068
Medicare patients
213
Services billed
1,159

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide135$167,200
MounjaroTirzepatide63$66,328
JardianceEmpagliflozin35$49,499
WegovySemaglutide24$31,449
EliquisApixaban29$21,085
MyrbetriqMirabegron12$12,037
Trelegy ElliptaFluticasone/Umeclidin/Vilanter12$11,432
VascepaIcosapent Ethyl12$9,818
FarxigaDapagliflozin Propanediol11$8,452
Breo ElliptaFluticasone/Vilanterol13$7,626
Rosuvastatin Calcium311$4,366
Wixela InhubFluticasone Propion/Salmeterol11$3,430
Atorvastatin Calcium269$2,569
Losartan Potassium185$2,358
Levothyroxine Sodium221$2,028

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic, Wegovy$254$198,648159 claims
Lilly USA, LLCMounjaro$114$66,32863 claims
Boehringer IngelheimJardiance$70$49,49935 claims
PfizerEliquis$61$21,08529 claims
Astellas Pharma US IncMyrbetriq$86$12,03712 claims
AstraZenecaFarxiga$52$8,45211 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 7,282 family medicine providers in Florida.

Other family medicine in Palmetto Bay

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →